Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Expert Opinion on Emerging Drugs|May 30, 2015
Advances in emerging drugs for osteosarcomaClaudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
Cancers|March 29, 2023
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide DerivativeValentina Pirota, Giovanni Bisbano, Massimo Serra, et al.
Expert Review of Molecular Diagnostics|October 17, 2018
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, et al.
Cells|November 27, 2019
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer DrugsMayra Paolillo, Raffaella Colombo, Massimo Serra, et al.
International Journal of Molecular Sciences|November 27, 2024
The Interplay Between the <i>MYC</i> Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic TargetsAnia Naila Guerrieri, Claudia Maria Hattinger, Federica Marchesini, et al.
Cells|September 28, 2021
Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?Massimo Serra, Claudia Maria Hattinger, Michela Pasello, et al.
Anti-Cancer Drugs|March 22, 2006
No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcomaGaetano Bacci, Loretta Loro, Alessandra Longhi, et al.
Molecules (Basel, Switzerland)|October 28, 2023
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition EraGiacomo Rossino, Emanuela Marchese, Giovanni Galli, et al.
Plos One|November 30, 2016
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsSerena Vella, Elisa Tavanti, Claudia Maria Hattinger, et al.
International Journal of Cancer|December 4, 2003
Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospectsStefania Benini, Maria Cristina Manara, Vanessa Cerisano, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Expert Opinion on Emerging Drugs|May 30, 2015
Advances in emerging drugs for osteosarcomaClaudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
Cancers|March 29, 2023
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide DerivativeValentina Pirota, Giovanni Bisbano, Massimo Serra, et al.
Expert Review of Molecular Diagnostics|October 17, 2018
Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, et al.
Cells|November 27, 2019
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer DrugsMayra Paolillo, Raffaella Colombo, Massimo Serra, et al.
International Journal of Molecular Sciences|November 27, 2024
The Interplay Between the <i>MYC</i> Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic TargetsAnia Naila Guerrieri, Claudia Maria Hattinger, Federica Marchesini, et al.
Cells|September 28, 2021
Impact of ABC Transporters in Osteosarcoma and Ewing's Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?Massimo Serra, Claudia Maria Hattinger, Michela Pasello, et al.
Anti-Cancer Drugs|March 22, 2006
No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcomaGaetano Bacci, Loretta Loro, Alessandra Longhi, et al.
Molecules (Basel, Switzerland)|October 28, 2023
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition EraGiacomo Rossino, Emanuela Marchese, Giovanni Galli, et al.
Plos One|November 30, 2016
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsSerena Vella, Elisa Tavanti, Claudia Maria Hattinger, et al.
International Journal of Cancer|December 4, 2003
Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospectsStefania Benini, Maria Cristina Manara, Vanessa Cerisano, et al.
Pageof 16